Individual variation in a cholinergic receptor gene modulates attention

[1]  H. Kaiser.  An index of factorial simplicity , 1974 .

[2]  E. Masliah,et al.  Quantitative synaptic alterations in the human neocortex during normal aging , 1993, Neurology.

[3]  ML Voytko,et al.  Basal forebrain lesions in monkeys disrupt attention but not learning and memory [published erratum appears in J Neurosci 1995 Mar;15(3): following table of contents] , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  M. Davidson,et al.  Effects of altering brain cholinergic activity on covert orienting of attention: comparison of monkey and human performance , 1997, Psychopharmacology.

[5]  B. Connors,et al.  Differential Regulation of Neocortical Synapses by Neuromodulators and Activity , 1997, Neuron.

[6]  E. Levin,et al.  Nicotinic acetylcholine involvement in cognitive function in animals , 1998, Psychopharmacology.

[7]  P. Clarke,et al.  Nicotinic receptors in the rat prefrontal cortex: increase in glutamate release and facilitation of mediodorsal thalamo‐cortical transmission , 1999, The European journal of neuroscience.

[8]  R. Parasuraman,et al.  Acetylcholine affects the spatial scale of attention: evidence from Alzheimer's disease. , 2000, Neuropsychology.

[9]  J. Cohen,et al.  Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control. , 2000, Science.

[10]  J. Haxby,et al.  Cholinergic enhancement and increased selectivity of perceptual processing during working memory. , 2000, Science.

[11]  V. Brown,et al.  Cholinergic neurotransmission influences covert orientation of visuospatial attention in the rat , 2000, Psychopharmacology.

[12]  H. Eisenberg,et al.  Nicotinic Receptor Activation in Human Cerebral Cortical Interneurons: a Mechanism for Inhibition and Disinhibition of Neuronal Networks , 2000, The Journal of Neuroscience.

[13]  S. Sikström,et al.  Aging cognition: from neuromodulation to representation , 2001, Trends in Cognitive Sciences.

[14]  H. D. Gage,et al.  Cholinergic activity of aged rhesus monkeys revealed by positron emission tomography , 2001, Synapse.

[15]  E. Stein,et al.  Cognitive Mechanisms of Nicotine on Visual Attention , 2002, Neuron.

[16]  N. Bohnen,et al.  Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. , 2003, Archives of neurology.

[17]  C. Gotti,et al.  Neuronal nicotinic receptors: from structure to pathology , 2004, Progress in Neurobiology.

[18]  A. Nordberg.  Functional studies of cholinergic activity in normal and Alzheimer disease states by imaging technique. , 2004, Progress in brain research.

[19]  R. Dolan,et al.  Effects of Cholinergic Enhancement on Visual Stimulation, Spatial Attention, and Spatial Working Memory , 2004, Neuron.

[20]  M. Reuter,et al.  The influence of the dopaminergic system on cognitive functioning: A molecular genetic approach , 2005, Behavioural Brain Research.

[21]  K. Zilles,et al.  Nicotine Modulates Reorienting of Visuospatial Attention and Neural Activity in Human Parietal Cortex , 2005, Neuropsychopharmacology.

[22]  Raja Parasuraman,et al.  Specificity of the Effect of a Nicotinic Receptor Polymorphism on Individual Differences in Visuospatial Attention , 2005, Journal of Cognitive Neuroscience.

[23]  C. Surowy,et al.  Different nicotinic acetylcholine receptor subtypes mediating striatal and prefrontal cortical [3H]dopamine release , 2005, Neuropharmacology.

[24]  R. Parasuraman,et al.  Beyond Heritability , 2005, Psychological science.

[25]  N. Bohnen,et al.  Cognitive correlates of alterations in acetylcholinesterase in Alzheimer's disease , 2005, Neuroscience Letters.

[26]  N. Bohnen,et al.  Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and parkinsonian dementia , 2006, Journal of Neurology.

[27]  M. Zoli,et al.  Brain nicotinic acetylcholine receptors: native subtypes and their relevance. , 2006, Trends in pharmacological sciences.

[28]  R. Parasuraman,et al.  Interactive effects of APOE and CHRNA4 on attention and white matter volume in healthy middle-aged and older adults , 2006, Cognitive, affective & behavioral neuroscience.

[29]  M. Mesulam.  Cholinergic pathology of the aging-mild cognitive impairment-Alzheimer's disease continuum: functional and therapeutic implications , 2006 .

[30]  E. Masliah,et al.  Synaptic remodeling during aging and in Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.

[31]  A. Wall,et al.  PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer’s disease , 2006, Psychopharmacology.

[32]  P. Stoeter,et al.  Association of attentional network function with exon 5 variations of the CHRNA4 gene. , 2007, Human molecular genetics.

[33]  I. Reinvang,et al.  Nicotine receptor gene CHRNA4 modulates early event-related potentials in auditory and visual oddball target detection tasks , 2007, Neuroscience.

[34]  S. Janhunen,et al.  Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: Implications for drug development , 2007, Neuroscience & Biobehavioral Reviews.

[35]  Parasuraman,et al.  Genetic and neuroimaging studies of cholinergic-neurotrophic modulation of visual attention , 2007 .

[36]  J. Buccafusco,et al.  Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys. , 2007, Biochemical pharmacology.

[37]  Roland Bammer,et al.  Cognitive processing speed and the structure of white matter pathways: Convergent evidence from normal variation and lesion studies , 2008, NeuroImage.

[38]  J. Seibyl,et al.  Age-related decline in nicotinic receptor availability with [123I]5-IA-85380 SPECT , 2009, Neurobiology of Aging.

[39]  M. Teare.  Candidate gene association studies. , 2011, Methods in molecular biology.